Loading...
Loading...
Shares of ViroPharma
VPHM are lower on the session by 1.01%, currently trading at $29.49. The stock has been moving largely lower over the past two weeks and is currently testing the 50-day moving average.
Options traders are focusing on calls today. The strike seeing the heaviest volume is the March 2012 $30.00 call, which has traded 5,000 times on open interest of 5,272 contracts.
Calls are outpacing puts today by 19 to 1.
ViroPharma Incorporated is a global biotechnology company focused on the development and commercialization of products that address diseases, with a focus on products used by physician specialists or in hospital settings.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in